SC 13D

Company

SOLENO THERAPEUTICS INC

Filed

March 13, 2017

Accession Number

0001615774-17-001016

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →